Diabetes diagnostics app developer Telcare has now raised almost $70m in total after a series C round featuring Qualcomm, which made its third investment in the company.
US-based digital health company Telcare has received $32.5m in a series C round that featured Qualcomm Ventures, the corporate venturing division of communications technology manufacturer Qualcomm.
The round was led by Wells Fargo-backed venture capital firm Norwest Venture Partners, and also included Mosaic Health Solutions and VC firm Sequoia Capital.
Telcare has developed a mobile app that monitors blood glucose levels to spot diabetes. The funding will be used to increase its work in diabetes and to expand the platform…
